These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10190743)

  • 1. Lamivudine is safe and effective in fulminant hepatitis B.
    Santantonio T; Mazzola M; Pastore G
    J Hepatol; 1999 Mar; 30(3):551. PubMed ID: 10190743
    [No Abstract]   [Full Text] [Related]  

  • 2. A possible role for lamivudine as prophylaxis against hepatitis B reactivation in carriers of hepatitis B who undergo chemotherapy and autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
    Endo T; Sakai T; Fujimoto K; Yamamoto S; Takashima H; Haseyama Y; Nishio M; Koizumi K; Koike T; Sawada K
    Bone Marrow Transplant; 2001 Feb; 27(4):433-6. PubMed ID: 11313673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamivudine treatment for acute hepatitis B virus infection during allogeneic peripheral blood stem cell transplantation.
    Efremov DG; Georgievski B; Cevreska L; Pivkova A; Panovska I
    Bone Marrow Transplant; 2003 Mar; 31(6):515-6. PubMed ID: 12665850
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effective treatment with Lamivudine of patients with reactivation of hepatitis B following chemotherapy administration].
    Shtalrid M; Haran M; Klepfish A; Lurie Y; Malnick S
    Harefuah; 2001 Dec; 140(12):1159-62, 1230, 1229. PubMed ID: 11789300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection.
    Ahmed A; Keeffe EB
    Am J Gastroenterol; 1999 Jan; 94(1):249-51. PubMed ID: 9934765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of chronic hepatitis B virus infection with the nucleoside analog lamivudine].
    Jung MC; Zachoval R; Sackmann M
    Z Gastroenterol; 1996 Dec; 34(12):827-8. PubMed ID: 9082663
    [No Abstract]   [Full Text] [Related]  

  • 7. Preemptive lamivudine in hepatitis B patients undergoing chemotherapy.
    Del Poggio P; Jamoletti C; Zaccanelli M
    Gastroenterology; 2004 Jun; 126(7):1924; author reply 1924-5. PubMed ID: 15188202
    [No Abstract]   [Full Text] [Related]  

  • 8. Beneficial effect of lamivudine pre- and post-liver transplantation for hepatitis B infection.
    Ben-Ari Z; Shmueli D; Mor E; Shaharabani E; Bar-Nathan N; Shapira Z; Tur-Kaspa R
    Transplant Proc; 1997 Sep; 29(6):2687-8. PubMed ID: 9290790
    [No Abstract]   [Full Text] [Related]  

  • 9. Lamivudine and glycyrrhizin for treatment of chemotherapy-induced hepatitis B virus (HBV) hepatitis in a chronic HBV carrier with non-Hodgkin lymphoma.
    Matsuo K; Takenaka K; Shimomura H; Fujii N; Shinagawa K; Kiura K; Harada M
    Leuk Lymphoma; 2001 Mar; 41(1-2):191-5. PubMed ID: 11342373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP.
    Dai MS; Chao TY; Kao WY; Shyu RY; Liu TM
    Ann Hematol; 2004 Dec; 83(12):769-74. PubMed ID: 15338194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamivudine-resistant hepatitis B virus and ongoing lamivudine therapy: stop the merry-go-round, it's time to get off!
    Angus P; Locarnini S
    Antivir Ther; 2004 Apr; 9(2):145-8. PubMed ID: 15134176
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute hepatitis B by sexual transmission after interruption of lamivudine-containing antiretroviral regimen.
    Liuzzi G; Zaccarelli M; Sette P; Grisetti S; Alba L; Antinori A
    AIDS; 2001 Oct; 15(15):2062-3. PubMed ID: 11600843
    [No Abstract]   [Full Text] [Related]  

  • 13. Lamivudine treatment for acute severe hepatitis B: report of a case and review of the literature.
    Roussos A; Koilakou S; Kalafatas I; Kalantzis C; Apostolou N; Grivas E; Raptis N; Mantzaris G
    Acta Gastroenterol Belg; 2008; 71(1):30-2. PubMed ID: 18396747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HBV associated nephrotic syndrome: resolution with oral lamivudine.
    Connor FL; Rosenberg AR; Kennedy SE; Bohane TD
    Arch Dis Child; 2003 May; 88(5):446-9. PubMed ID: 12716723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of hepatitis B virus genotype on the development of lamivudine resistance during long-term treatment.
    Akuta N; Suzuki F; Kobayashi M; Tsubota A; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
    J Hepatol; 2003 Mar; 38(3):315-21. PubMed ID: 12586297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamivudine-stavudine-induced liver failure in hepatitis B cirrhosis.
    Schiano TD; Lissoos TW; Ahmed A; Siano C; Zaitman D; Cohn G; Ehrenpreis ED
    Am J Gastroenterol; 1997 Sep; 92(9):1563-4. PubMed ID: 9317091
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lamivudine for the prevention of chronic hepatitis B exacerbations during chemotherapy for non-Hodgkin's lymphoma].
    van der Eijk AA; Doorduijn JK; Janssen HL; Schalm SW; Niesters HG; de Man RA
    Ned Tijdschr Geneeskd; 2002 Jun; 146(24):1140-4. PubMed ID: 12092307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation.
    Buti M; Mas A; Prieto M; Casafont F; González A; Miras M; Herrero JI; Jardí R; Cruz de Castro E; García-Rey C
    J Hepatol; 2003 Jun; 38(6):811-7. PubMed ID: 12763375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal fulminant hepatitis B after withdrawal of prophylactic lamivudine in hematopoietic stem cell transplantation patients.
    Lin PC; Poh SB; Lee MY; Hsiao LT; Chen PM; Chiou TJ
    Int J Hematol; 2005 May; 81(4):349-51. PubMed ID: 15914368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of lamivudine for patients with acute hepatitis B (a series of cases).
    Kondili LA; Osman H; Mutimer D
    J Viral Hepat; 2004 Sep; 11(5):427-31. PubMed ID: 15357647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.